In this week’s fashion headlines, the FW25 season arrived with newcomers debuting and familiar faces returning, luxury shares ...
Luxury bellwether regains crown as drugmaker slips on concerns it will have to cut weight loss medication prices in US ...
Richemont delivered stunning holiday quarter performance with luxury jewelry sales up 14%, while Signet reported holiday ...
France's cognac industry is particularly exposed to the U.S. market, its biggest by volume, and memories of a trade dispute ...
It’s taken LVMH nearly a year-and-a-half to regain its spot as Europe’s biggest stock from Novo Nordisk A/S. The Danish ...
Bernard Arnault is outpacing Elon Musk and Mark Zuckerberg in wealth gain this year after signs of a rebound in luxury demand ...
Richemont has reported a 10% increase in its Q3 sales to €6.2bn (£5.2bn), driven by its jewellery sales which saw a 14% rise ...
The White House on Friday said Novo Nordisk's weight-loss drugs Wegovy and Ozempic were among the 15 medications picked for a round of price negotiations with Medicare. The companies do not have to ...
Secondary market watch price trackers including the Subdial Bloomberg index and Chronopulse by Chrono24 are showing prices ...
Facing a $39 billion bid from mining giant BHP Group Ltd, the London-listed company is considering offloading the diamond ...
Positive data from China, the probable exclusion from Trump's tariffs, the first decidedly positive quarterly results for the ...
Richemont, owner of Cartier, reported a 10% year-on-year increase in Q3 sales, significantly surpassing expectations. This ...